Cancer Treatment

Oral Xeloda Plus Oxaliplatin Is Comparable To FOLFOX As Colorectal Cancer Treatment

Overall survival results from a 14-month follow-up of the international, Phase III NO16966 study confirm that oral Xeloda plus oxaliplatin (XELOX) is comparable to a current standard treatment, FOLFOX-4 (infused 5-FU/leucovorin plus oxaliplatin) in the first-line treatment of advanced (metastatic) colorectal cancer. In the study, patients receiving XELOX lived for a median of 19.0 months, [...]

Cancer Killing Viruses Influence Tumor Blood-Vessel Growth

Viruses genetically designed to kill cancer cells offer a promising strategy for treating incurable brain tumors such as glioblastoma, but the body’s natural defenses often eliminate the viruses before they can eliminate the tumor. The findings of an animal study by researchers at the Ohio State University Comprehensive Cancer Center help explain why this happens [...]